RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study	HER2 positive breast carcinoma, Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast carcinoma, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Not stated	2025-06-22		NCT07030569

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	62

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fondazione IRCCS Istituto Nazionale Tumori	Milan	Italy	10

Clinical trials